瑞士股票 - 10 月 2 日值得关注的因素

路透中文

Oct 02

瑞士股票 - 10 月 2 日值得关注的因素

路透社苏黎世/丹麦10月2日 - 以下是周四可能影响瑞士股市的一些主要因素：

制药

瑞士一家主要的化学和制药行业协会周三表示，在唐纳德-特朗普总统推动降低处方药价格导致与辉瑞 (link)，以换取关税减免之后，瑞士制药商 (link)，可能会与美国达成自己的协议。欧洲和美国医疗保健类股周三大涨。

公司声明

* 罗氏ROG.S称 (link)，该公司开始要约收购89BioETNB.O的全部股份

分析师观点

*BARRY CALLEBAUT AG BARN.S - 贝伦贝格将其评级从 "买入 "下调至 "持有"；将目标价从 1110 瑞士法郎上调至 1200 瑞士法郎。

经济

瑞士 CPI 将于北京时间 06:30 公布。

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

有关 Eikon 多媒体网络格式的热门新闻，请访问： https://bit.ly/2NDFd6g 

 有关相关价格、新闻和其他主题，请双击：
德文版每日瑞士股市报告 .SDE
所有 SMI 成分股 0#.SSMI
DJ STOXX 指数 .STOXX
10 大 STOXX 板块 .PGL.STOXXS
10 大 EUROSTOXX 板块 .PGL.STOXXES

瑞士中盘股指数 .SSMI
瑞士全股票指数 .SSHI
瑞士市场文摘 .AD.S
行业概览 CH/SECTOR1
所有瑞士新闻 CH
瑞士研究新闻 CH-RCH
所有股票新闻 E

快速指南： EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2572595471"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572595471\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572595471?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-10-02 12:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572595471","market":"us","top_or_hot":-1,"title":"瑞士股票 - 10 月 2 日值得关注的因素","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>瑞士股票 - 10 月 2 日值得关注的因素</title></head><body><p>\n<span>路透社苏黎世/丹麦10月2日</span><span> - </span>以下是周四可能影响瑞士股市的一些主要因素：</p><p>制药 </p><p>瑞士一家主要的化学和制药行业协会周三表示，在唐纳德-特朗普总统推动降低处方药价格导致与<a href=\"https://laohu8.com/S/PFE\">辉瑞</a> (<span>link</span>)，以换取关税减免之后，瑞士制药商 (<span>link</span>)，可能会与美国达成自己的协议。欧洲和美国医疗保健类股周三大涨。</p><p>公司声明</p><p>* 罗氏<span>ROG.S</span>称 (<span>link</span>)，该公司开始要约收购89Bio<span>ETNB.O</span>的全部股份 </p><p>分析师观点</p><p>*BARRY CALLEBAUT AG <span>BARN.S</span> - 贝伦贝格将其评级从 \"买入 \"下调至 \"持有\"；将目标价从 1110 瑞士法郎上调至 1200 瑞士法郎。</p><p>经济</p><p>瑞士 CPI 将于北京时间 06:30 公布。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p><div><pre>有关 Eikon 多媒体网络格式的热门新闻，请访问： https://bit.ly/2NDFd6g <br/><br/> 有关相关价格、新闻和其他主题，请双击：<br/>德文版每日瑞士股市报告 <span>.SDE</span><br/>所有 SMI 成分股 <span>0#.SSMI</span><br/>DJ STOXX 指数 <span>.STOXX</span><br/>10 大 STOXX 板块 <span>.PGL.STOXXS</span><br/>10 大 EUROSTOXX 板块 <span>.PGL.STOXXES</span><br/><br/>瑞士中盘股指数 <span>.SSMI</span><br/>瑞士全股票指数 <span>.SSHI</span><br/>瑞士市场文摘 <span>.AD.S</span><br/>行业概览 <span>CH/SECTOR1</span><br/>所有瑞士新闻 <span>CH</span><br/>瑞士研究新闻 <span>CH-RCH</span><br/>所有股票新闻 <span>E</span><br/><br/>快速指南： <span>EQUITY</span>, <span>EQUITY/NEWS1</span>, <span>EUR/EQUITY</span>, <span>SWITZERLAND</span>, <span>REUTERS</span> \n</pre></div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞士股票 - 10 月 2 日值得关注的因素</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞士股票 - 10 月 2 日值得关注的因素\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-10-02 12:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>瑞士股票 - 10 月 2 日值得关注的因素</title></head><body><p>\n<span>路透社苏黎世/丹麦10月2日</span><span> - </span>以下是周四可能影响瑞士股市的一些主要因素：</p><p>制药 </p><p>瑞士一家主要的化学和制药行业协会周三表示，在唐纳德-特朗普总统推动降低处方药价格导致与<a href=\"https://laohu8.com/S/PFE\">辉瑞</a> (<span>link</span>)，以换取关税减免之后，瑞士制药商 (<span>link</span>)，可能会与美国达成自己的协议。欧洲和美国医疗保健类股周三大涨。</p><p>公司声明</p><p>* 罗氏<span>ROG.S</span>称 (<span>link</span>)，该公司开始要约收购89Bio<span>ETNB.O</span>的全部股份 </p><p>分析师观点</p><p>*BARRY CALLEBAUT AG <span>BARN.S</span> - 贝伦贝格将其评级从 \"买入 \"下调至 \"持有\"；将目标价从 1110 瑞士法郎上调至 1200 瑞士法郎。</p><p>经济</p><p>瑞士 CPI 将于北京时间 06:30 公布。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p><div><pre>有关 Eikon 多媒体网络格式的热门新闻，请访问： https://bit.ly/2NDFd6g <br/><br/> 有关相关价格、新闻和其他主题，请双击：<br/>德文版每日瑞士股市报告 <span>.SDE</span><br/>所有 SMI 成分股 <span>0#.SSMI</span><br/>DJ STOXX 指数 <span>.STOXX</span><br/>10 大 STOXX 板块 <span>.PGL.STOXXS</span><br/>10 大 EUROSTOXX 板块 <span>.PGL.STOXXES</span><br/><br/>瑞士中盘股指数 <span>.SSMI</span><br/>瑞士全股票指数 <span>.SSHI</span><br/>瑞士市场文摘 <span>.AD.S</span><br/>行业概览 <span>CH/SECTOR1</span><br/>所有瑞士新闻 <span>CH</span><br/>瑞士研究新闻 <span>CH-RCH</span><br/>所有股票新闻 <span>E</span><br/><br/>快速指南： <span>EQUITY</span>, <span>EQUITY/NEWS1</span>, <span>EUR/EQUITY</span>, <span>SWITZERLAND</span>, <span>REUTERS</span> \n</pre></div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nL3S3VJ07M:1","article_id":"2572595471","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572595471","pubTimestamp":1759380593,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"路透社苏黎世/丹麦10月2日 - 以下是周四可能影响瑞士股市的一些主要因素：制药 瑞士一家主要的化学和制药行业协会周三表示，在唐纳德-特朗普总统推动降低处方药价格导致与辉瑞 ，以换取关税减免之后，瑞士制药商 ，可能会与美国达成自己的协议。经济瑞士 CPI 将于北京时间 06:30 公布。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4599":"减肥药","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","BK4139":"生物科技","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999002232.USD":"Allianz Global High Payout USD","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0122379950.USD":"贝莱德世界健康科学A2","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","SG9999001176.USD":"United Global Healthcare Acc USD","ETNB":"89Bio, Inc.","LU0058720904.USD":"联博国际健康护理基金A","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4592":"伊斯兰概念","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4581":"高盛持仓","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","BK4588":"碎股","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC"},"translate_title":"Swiss Stocks-Factors to Watch for October 2","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ETNB":0.9},"content_text":"瑞士股票 - 10 月 2 日值得关注的因素\n路透社苏黎世/丹麦10月2日 - 以下是周四可能影响瑞士股市的一些主要因素：制药 瑞士一家主要的化学和制药行业协会周三表示，在唐纳德-特朗普总统推动降低处方药价格导致与辉瑞 (link)，以换取关税减免之后，瑞士制药商 (link)，可能会与美国达成自己的协议。欧洲和美国医疗保健类股周三大涨。公司声明* 罗氏ROG.S称 (link)，该公司开始要约收购89BioETNB.O的全部股份 分析师观点*BARRY CALLEBAUT AG BARN.S - 贝伦贝格将其评级从 \"买入 \"下调至 \"持有\"；将目标价从 1110 瑞士法郎上调至 1200 瑞士法郎。经济瑞士 CPI 将于北京时间 06:30 公布。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)有关 Eikon 多媒体网络格式的热门新闻，请访问： https://bit.ly/2NDFd6g  有关相关价格、新闻和其他主题，请双击：德文版每日瑞士股市报告 .SDE所有 SMI 成分股 0#.SSMIDJ STOXX 指数 .STOXX10 大 STOXX 板块 .PGL.STOXXS10 大 EUROSTOXX 板块 .PGL.STOXXES瑞士中盘股指数 .SSMI瑞士全股票指数 .SSHI瑞士市场文摘 .AD.S行业概览 CH/SECTOR1所有瑞士新闻 CH瑞士研究新闻 CH-RCH所有股票新闻 E快速指南： EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}